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Abstract 51 
 52 
Alcohol induced liver damage is a major burden for most societies, and murine 53 
studies can provide a means to better understand its pathogenesis and test new 54 
therapies. However, there are many models reported with widely differing 55 
phenotypes, not all of which fully recreate the spectrum of human disease. Thus 56 
understanding the implications of these variations is key for clinicians/clinician 57 
scientists who wish to model human disease. 58 
 59 
This review critically appraises key papers in the field, detailing the spectrum of liver 60 
damage seen in different models, and how they relate to the phenotype of disease 61 
seen in patients. A range of different methods of alcohol administration have been 62 
studied ranging from ad libitum consumption of alcohol and water to modified diets 63 
e.g. Lieber deCarli liquid diet. Other feeding regimens have taken more invasive 64 
routes using intra-gastric feeding tubes to infuse alcohol directly into the stomach. 65 
Notably, models utilising wild-type (WT) mice generally produce a milder phenotype 66 
of liver damage than those using genetically modified mice, with the exception of the 67 
chronic binge feeding model.  68 
 69 
The review also recommends panels of tests that should be considered so as to 70 
standardise end-points for the evaluation of the severity of liver damage. This is key 71 
for comparison of models of injury, testing of new therapies, and for subsequent 72 
translation of findings into clinical practice. 73 
 74 Comment [RW1]: Abstract cut down to 220 words. 
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Introduction 75 
 76 
The burden of alcohol and related liver disease is significant, in terms of both human 77 
and financial costs. In 2010, 7.2 deaths per 100 000 people globally were caused by 78 
alcohol related cirrhosis equating to 0.9% of deaths from all causes(1). The economic 79 
burden is much more difficult to calculate, and the World Health Organisation 80 
estimated that in 2003, the total tangible cost of alcohol to EU society was 125 billion 81 
euros, with non-tangible costs (value placed on pain, suffering and lost life due to 82 
social and health harms caused by alcohol) amounting to 150-760 billion euros(2). 83 
Whilst alcohol excess is a major cause of cirrhosis, as many as 60% of patients 84 
presenting with alcohol induced liver damage also have evidence of concomitant 85 
acute alcoholic hepatitis (AAH)(3). As the most dramatic presentation of alcohol-86 
induced liver injury, AAH has a much higher short and long-term mortality 87 
approaching 20% and 50% respectively, despite current medical therapy(4, 5). The 88 
understanding of its pathogenesis and hence development of novel therapies has 89 
been in part hampered by the lack of relevant, reproducible animal models of 90 
AAH(6). 91 
 92 
Whilst there are limitations of using animal models to investigate alcoholic liver injury, 93 
this approach does provide research opportunities not found in in vitro or clinical 94 
studies. Animal models allow control over multiple pathogenetic factors such as the 95 
environment, contribution of specific pathways and the amount of alcohol consumed, 96 
which are difficult to replicate in human studies. Mice that are transgenic for key 97 
inflammatory and metabolic disease modifying genes are widely available, and 98 
confer the ability to assess the impact of regulatory processes on the induction of 99 
alcoholic liver injury(7). While transgenic rats are available their use has been 100 
restricted by a limited knowledge of their reproductive system and more difficult in 101 
vitro embryo manipulation which is needed to develop transgenic breeds. Therefore, 102 
 5 
in this review we will critically appraise the published models of acute murine alcohol-103 
induced liver injury, paying particular attention to the parameters used to define the 104 
extent of liver damage, in order to highlight advantages of those models with the 105 
greatest promise for new treatment options. 106 
 107 
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Phenotype of disease 108 
 109 
Alcohol induces a broad spectrum of liver injury in patients ranging from steatosis, to 110 
more florid inflammation and hepatocyte necrosis, and finally to fibrosis and the 111 
development of hepatocellular carcinoma. The particular phenotype induced is 112 
determined in part by the quantity and duration of alcohol exposure as well as patient 113 
specific factors. A variety of models have been used by researchers to model this 114 
spectrum(6), with each utilising a different method of alcohol administration to 115 
produce a desired pattern of liver injury. In general however, whilst many of the 116 
available murine models reproduce some of the early stages of liver injury, the 117 
development of fibrosis and cirrhosis is harder to replicate and commonly requires an 118 
injury additional to alcohol exposure. Thus, whilst steatosis has been achieved by ad 119 
libitum feeding for between approximately one week to several months(7, 8), most 120 
models require a second insult alongside an extended course of alcohol 121 
administration in order to induce fibrosis such as either concomitant genetic 122 
manipulation(9) or the addition of a second chemical insult such as carbon 123 
tetrachloride (CCl4)(10).  124 
 7 
Use of Wild Type mice to model alcohol induced liver damage 125 
 126 
Alcohol has been administered to mice by a variety of different routes/regimens, each 127 
having their respective advantages and disadvantages (Table 1). Choice of model is 128 
often governed by the features of liver injury that are required and the 129 
skills/resources available. The simplest method of administering alcohol, known as 130 
ad libitum, is to mix it into the drinking water and allow the mouse free access to this 131 
alongside their normal chow. However, due to a natural aversion to alcohol, the mice 132 
generally only develop low blood alcohol levels (BAL) and mild liver injury(11). This 133 
model can be useful in some circumstances as it replicates human patterns of 134 
alcohol exposure and dietary intake. The other ad libitum option involves the addition 135 
of alcohol to a Lieber deCarli (LdC) diet, in which normal mouse chow is replaced by 136 
a high fat, nutritionally complete liquid diet. This partially overcomes the murine 137 
dislike of alcohol and tends to produce a more significant liver injury than the 138 
conventional water/alcohol mix(12). There is conflicting evidence as to whether the 139 
increased liver injury is a reflection of higher blood alcohol levels or the additive effect 140 
of combining a high fat diet with alcohol exposure(12, 13).  141 
 142 
Another ad libitum method is to provide the ethanol in an agar gel(14). This has been 143 
used much less commonly than a liquid diet although there is some evidence that the 144 
alcohol evaporation from a gel is low. The model was developed to try and simplify 145 
the administration of alcohol. The gel diet does appear to induce a liver injury- the 146 
alcohol fed mice developed a significantly higher steatosis score, triglyceride level 147 
and ALT level than control mice not fed alcohol. The drawback for this method is the 148 
complicated gel preparation and custom made feeding tubes required. In contrast the 149 
Lieber deCarli liquid diet is easier to make and Richter tubes are a simple delivery 150 
method. 151 
 152 
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Another approach consists of administering alcohol via gavage directly into the 153 
animal’s stomach, which is a relatively straightforward procedure that can be easily 154 
taught(15). However, the procedure needs to be repeated on a daily basis, thus 155 
inducing stress in the mouse, and again only produces mild liver injury with a 25% 156 
increase in serum alanine aminotransferase (ALT) levels in ethanol fed animals(16). 157 
The gavage model can be used in combination with ad libitum delivery of alcohol, 158 
such as in the chronic-binge model(17), where mice have access to a Lieber-159 
deCarli/ethanol mix and also receive a single gavage of ethanol on the day the 160 
experiment is terminated. This produces a more significant liver injury than just 161 
gavage or ad libitum delivery alone, with peak levels of ALT and aspartate 162 
aminotransferase (AST) 9 hours post-gavage of 250IU and 420 IU respectively(18). 163 
Notably, there is also evidence of greater triglyceride deposition in the liver and 164 
increased hepatic inflammation in the chronic binge group. The ability of this 165 
relatively simple model to induce a moderately severe alcoholic liver injury has led to 166 
its adoption by many groups(19).  167 
 168 
Recently, a hybrid model of a solid chow high in cholesterol and saturated fat along 169 
with intra-gastric feeding of a liquid high fat/ethanol diet has been developed by the 170 
Tsukamoto group(20). The intra-gastric feeding model was first described by 171 
Tsukamoto and French in 1985(21), and involves complex surgery to place a tube 172 
through the skin into the rodent’s stomach. This tube is then used to administer feed 173 
and alcohol to the mouse. It has been shown to produce higher BALs (between 100 174 
to 500mg/dL in rats)(6) and a more severe liver injury than ad libitum feeding 175 
methods(22). The hybrid model produces a liver injury consistent with chronic 176 
alcoholic steatohepatitis- with a marked transaminase rise, and significant steatosis 177 
with inflammation and occasional neutrophil infiltration present. The addition of 178 
weekly alcohol binges induces an increased neutrophil infiltration with clustering seen 179 
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around dead and fat-loaded hepatocytes. This provides a better representation of an 180 
acute alcoholic hepatitis injury (Figure 1). 181 
 182 
The length of high fat diet administration has been investigated by Chang et al. who 183 
fed mice for either three days or three months of high fat diet with a single gavage of 184 
alcohol on the final day of feeding(23). This model produced raised ALT/AST in the 3 185 
day model, with higher levels in the 3 month model. Increases in infiltrated 186 
neutrophils and serum free fatty acids were also seen, however, the activation 187 
markers of macrophages was only slightly increased by the alcohol binge compared 188 
to the model without the alcohol. This seems to partially correlate with the human 189 
picture of alcoholic hepatitis (see below). 190 
 191 
The diet composition is also very important. Lieber and deCarli developed their 192 
eponymously named diet to accentuate the liver injury that could be induced by 193 
alcohol administration and it has since been shown that a diet that is high in 194 
saturated fats can reduce hepatic lipid accumulation, whilst a diet containing 195 
polyunsaturated fats promotes liver injury. You et al. found that adiponectin mediated 196 
the protective effect of saturated fats, which may provide therapeutic options that 197 
should be explored(24). However, recently Chen et al. showed that while saturated 198 
fats can reduce hepatic fat deposition, they increased fibrotic changes within the 199 
liver(25). Importantly, the majority of murine studies follow a pair fed diet protocol. 200 
This involves matching the amount of diet without alcohol that is provided to control 201 
mice to the amount of diet and alcohol that the main study mice consumed in the 202 
previous 24 hours. This provides a control group to show that the liver injury is due to 203 
the alcohol and not the high fat diet. Ultimately, logistical issues may determine 204 
choice of regimen; ad libitum models require considerably less expertise and 205 
specialist equipment, whilst the more involved intra-gastric feeding model requires 206 
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metabolic cages, single mouse housing, specialist infusion equipment and surgery to 207 
be performed by the researcher.  208 
 209 
In WT mice the severity of liver damage is closely linked to the duration and quantity 210 
of alcohol consumption, both of which are strongly influenced by the method of 211 
alcohol delivery. The ad libitum methods are limited by the mouse’s appetite whereas 212 
the intra-gastric feeding method is limited by the length of time the mouse can 213 
tolerate a feeding cannula in its stomach. Consequently, the duration of each model 214 
is determined both by the tolerability of the model and the level of liver injury that is 215 
required. Thus, whilst there are advantages to using WT mice in such studies, the 216 
extended duration of alcohol exposure needed to generate more severe liver injury 217 
may be challenging, highlighting the potential advantages of using transgenic mice 218 
that have an increased susceptibility to the injurious effects of alcohol.219 
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Models of alcohol induced liver damage using genetically modified mice 220 
 221 
To date, multiple different regulatory and metabolic genes have been knocked out to 222 
assess their impact on the process of liver injury (see Table 2). Some of these affect 223 
normal pathways of ethanol metabolism or metabolism of harmful by-products of 224 
ethanol, such as the Nrf2 knockout mouse that is susceptible to oxidative stress 225 
caused by alcohol breakdown products(7). Others, such as the Hfe knockout mouse, 226 
which results in hepatic iron overload, augment the injurious effect of alcohol(11). 227 
Some of the more commonly used models with profound phenotypes are described 228 
in greater detail below, with a more comprehensive summary of models in Table 2. 229 
 230 
Nuclear factor-erythroid 2-related factor 2 (Nrf2) protects cells against xenobiotic and 231 
oxidative stress, such that mice with this gene knocked out incur a severe, acute 232 
form of acute liver injury after they ingest alcohol(7). Mice are typically given three 233 
days of Lieber deCarli diet for adaptation purposes, and then alcohol is added at 234 
increasing concentrations of 2.1%, 4.2% and 6.4% v/v for three-day blocks 235 
respectively. This gives a total of nine days of alcohol administration during which 236 
time significant amounts of hepatocellular damage were reported, as demonstrated 237 
by marked rises in ALT and development of clinical signs (7). The Nrf2-/- mouse thus 238 
provides a good model to study severe acute liver injury as seen in the setting of 239 
AAH where oxidative stress is an important factor (26, 27), although the high level of 240 
mortality reported necessitates close monitoring of mice. No evidence of liver fibrosis 241 
was presented in this model which potentially limits its utility given most patients with 242 
AAH have concomitant fibrosis, although its absence may be explained by the short 243 
duration of alcohol administration. However, it is possible that modification and 244 
extension of the regimen could potentially induce development of fibrosis. The acute 245 
onset of injury in this model presents a challenge as the cohort of mice with severe 246 
liver injury are identified by their moribund appearance and this occurs at varying 247 
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time points after exposure to the high concentration of alcohol making the model 248 
difficult to use for both logistic and ethical reasons.  249 
 250 
Other groups have targeted hepatic lipid homeostasis to exacerbate alcohol-induced 251 
liver injury. Lipin-1 is a vital regulator of lipid metabolism, acting as an enzyme in the 252 
triglyceride synthesis pathway and a transcriptional co-regulatory protein that is 253 
highly upregulated in alcoholic fatty liver disease. Hu et al. demonstrated that 254 
administering alcohol to mice with deletion of lipin-1 led to the rapid onset of severe 255 
liver injury, as indicated by levels of serum ALT and inflammatory cytokines, and 256 
progression to alcoholic steatohepatitis(28). In this study mice were fed low fat Lieber 257 
deCarli diet, with and without ethanol for four weeks. Wild type mice typically 258 
developed only mild liver injury while the lipin-1 knockout mice showed increased 259 
serum levels of ALT, AST, and free-fatty acids, as well as micro and macrovesicular 260 
steatosis suggesting that lipin-1 may exert a protective role by limiting inflammation 261 
and promoting efficient lipid storage and metabolism.  262 
 263 
Nishiyama et al. also investigated fat deposition(29). They used a hepatocyte specific 264 
HIF-1a null mouse to show that HIF-1 (Hypoxia inducible factor-1) has a protective 265 
role that reduces accumulation of lipids in the liver after ingestion of an alcohol/Lieber 266 
deCarli liquid diet. They were also able to show that HIF-1α suppresses Srebp-1c 267 
activity and that is at least part of the reason that when HIF-1α is removed, steatosis 268 
increases. However, there are conflicting reports regarding the role of hypoxia 269 
inducible factors. Nath et al. also used a HIF-1a null mouse and found a reduced 270 
injury in this knockout mouse(30) while Ni et al. achieved similar results using a HIF-271 
1b null mouse(31). The reasons for these contrasting results are not clear, although 272 
different housing conditions or development of sub-strains within the knockout 273 
populations have been suggested(32).  274 
 275 
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It is interesting to note that HIF have been implicated in the tissue repair response 276 
within the liver. They may be involved in regulating the angiogenic effect of hepatic 277 
macrophages that induce liver sinusoidal endothelial cell proliferation and 278 
migration(33). This appears to be a key step in liver repair after an acute injury. 279 
Macrophages are likely to be key to fully understanding the process of tissue repair in 280 
the liver. It has been shown that initially pro-inflammatory (Ly6Chi) macrophages can 281 
switch to a Ly6Clow phenotype important in tissue repair(34) after phagocytosis of 282 
apoptotic hepatocytes. Further characterization of the mechanisms driving tissue 283 
repair in alcoholic liver injury are needed to identify targets for potential therapies.  284 
 285 
Other pathways that have been targeted in the attempt to augment hepatic injury 286 
following alcohol exposure include Pparα. Pparα is a nuclear hormone receptor and 287 
transcription factor that regulates hepatic inflammation and lipid metabolism. The role 288 
of this receptor is to stimulate fatty acid catabolism under fasting conditions and so 289 
the authors of this study(8) anticipated that free fatty acid production associated with 290 
alcohol consumption would normally activate Pparα. The Ppara knockout mouse was 291 
given ad libitum Lieber deCarli liquid diet with 4% ethanol for up to six months 292 
resulting in the development of both an inflammatory cell infiltrate and fibrotic 293 
changes that were not seen in alcohol fed WT mice. This was confirmed by both 294 
Picrosirius red and alpha smooth muscle actin staining, and demonstration of 295 
induction of genes involved in fibrosis including Thbs1, Col1a1 and Col1a2.  Ppara 296 
transgenic mice with additional genetic alterations provide further options to 297 
investigate liver injury. The Glutathione S-transferase A4-4/ Peroxisome proliferator 298 
activated receptor-α (Gsta4-4/Pparα) mouse has been described recently(35). Gsta4-299 
4 is an enzyme that protects against natural and environmental toxicants through 300 
glutathione conjugation which protects against harmful aldehydes, including 4-301 
Hydroxynonenal (4-Hne). Ronis et al. have used this double knockout in an ad libitum 302 
Lieber deCarli/5% EtOH model to show the central role lipid peroxidation plays in 303 
Comment [RW2]: New text added to discuss the papers investigating HIF and the tissue repair response. 
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mediating progression of alcohol-induced necro-inflammatory liver injury, stellate cell 304 
activation, matrix remodeling and fibrosis(35). 305 
 306 
Other alternatives to transgenic knockout mice include transfecting mice with 307 
adenoviruses to silence the expression of a specific gene, This reduces but does not 308 
completely turn off gene expression. The Postic group used this method to show that 309 
silencing the Carbohydrate Responsive Element Binding Protein (ChREBP) prevents 310 
alcohol induced steatosis in an acute model of injury(36). Another strategy is to 311 
genetically alter mice to over express a certain gene. Butura et al. used this method 312 
to investigate the role of the Cyp2e1 gene(37). They inserted approximately 20 extra 313 
copies of the gene into mice. They found that overexpression of this gene aggravates 314 
the liver injury with increased levels of oxidative stress. 315 
 316 
Fibrosis 317 
 318 
The generation of alcohol induced fibrosis in mouse models is more challenging than 319 
steatosis and inflammation and often requires a second injurious element in addition 320 
to alcohol ingestion. Bataller and Gao have published a comprehensive review on 321 
liver fibrosis in alcoholic liver disease and should be read for further information(38). 322 
There are a variety of non-alcohol models that are utilized to induce liver fibrosis, with 323 
one of the most commonly used being carbon tetrachloride(CCl4). This involves 324 
repeated intraperitoneal injections of CCl4 over a period of weeks, although there are 325 
no studies directly comparing the liver fibrosis induced by CCl4 or alcohol. The Nagy 326 
research group were able to induce liver fibrosis by administering CCl4 and moderate 327 
alcohol intake at a level not usually producing a significant liver injury. This proves 328 
the additive effect of the two agents through common pathways(10). Roychowdury et 329 
al. compared a high ethanol feeding regime against a moderate ethanol regime with 330 
the addition of CCl4(39). They demonstrated that steatosis, inflammation and 331 
 15 
apoptosis were more prevalent in the alcohol only group as compared to the group 332 
that also received CCl4, which had more prominent fibrosis. 333 
 334 
Chiang et al. exposed mice to 2% alcohol ad libitum for either 2 days, 2 weeks or 5 335 
weeks alongside administration of CCl4, which resulted in characteristic hepatic 336 
extracellular matrix deposition and a change in sinusoidal architecture(10). 337 
Genetically modified mice deficient in the HFe iron transporter, which causes 338 
accumulation of hepatic iron, develop a marked steatohepatitis and fibrosis upon 339 
administration of a high fat diet with ethanol(9). Versions of this dietary protocol have 340 
also been used by other groups combined with other genetic backgrounds. For 341 
example, Li et al. treated Ppara knockout mice with a 4% ethanol/Lieber deCarli 342 
diet(8), and after 4-6 months reported fibrosis with a small amount of collagen 343 
deposition in peri-venular and peri-cellular regions. Importantly, in common with other 344 
models, a major drawback of this study was the length of time required for fibrosis to 345 
develop, as well as the relatively modest amount of fibrosis seen. Notably, other 346 
groups have demonstrated that similar or longer regimens are not able to induce 347 
significant fibrosis in WT mice, necessitating further study of specific transgenic 348 
animals and alternate models of alcohol delivery(8, 40). 349 
 350 
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Mouse variables that affect experimental endpoints 351 
 352 
There are practical benefits in using a model where mice freely consume alcohol in 353 
large quantities. However as noted above, most mouse strains are not inclined to 354 
voluntarily ingest alcohol and this means that modified liquid diets, gavage or intra-355 
gastric infusion are often required. There are marked strain differences in murine 356 
attraction to alcohol, and one of the more comprehensive studies compared the 357 
consumption of unsweetened alcohol, sweetened alcohol and sweetened water in 22 358 
in-bred strains of mouse(41). C57Bl/6J strain of mice freely consumed the most 359 
alcohol, drinking more than 10g/kg/day compared to less than 2g/kg/day consumed 360 
by DBA/2J mice. Moreover, it has been shown that C57Bl/6 mice would consume 361 
diet containing a higher concentration of alcohol than other strains of mice(42). 362 
Patterns of alcohol consumption over time were also explored, and notably, mice with 363 
restricted daily access to alcohol consumed similar quantities to mice that had 364 
unlimited 24 hour access(43), with both groups having similar blood alcohol 365 
levels(42). It is not clear why the C57Bl/6 mice are able to consume higher 366 
concentrations of alcohol but there are parallels with consumption in humans where 367 
there is a marked difference in susceptibility to alcohol induced liver damage across 368 
ethnic groups (44). 369 
 370 
Gender is also an important factor in development of alcohol induced liver injury. 371 
Female patients are more susceptible to developing more advanced alcoholic liver 372 
damage both after acute and chronic administration(45), and similarly female mice 373 
develop more florid liver injury than males after exposure to ethanol(46). There are 374 
several different theories pertaining to this gender difference including different 375 
alcohol elimination rates, different alcohol pharmacokinetics and different oestrogen 376 
levels. Frezza et al. were the first to show that in humans, females have decreased 377 
levels of gastric ADH which lessens the ‘first pass effect’ on alcohol and increases 378 
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the bioavailability of ingested alcohol when compared to males(47). Female mice 379 
develop less liver fibrosis when exposed to other types of chronic liver damage, such 380 
as CCl4 injury or hepatitis C virus infection, suggesting that oestrogens may have a 381 
protective effect in some disease settings(48, 49). Work still needs to be done to 382 
ascertain whether this also applies to alcoholic liver injury but it does appear that 383 
treatment with oestrogen in females lacking ovaries reduces hepatic steatosis(50). 384 
Also, there are significant gender differences in the response to alcohol at a 385 
proteomic level. Wang et al. found that 78 protein levels were altered by either male 386 
or female mice undergoing chronic alcohol feeding and this included several 387 
oxidative stress related proteins. This is consistent with studies in rats that have 388 
found that oxidative stress is a possible reason for increased liver injury in females 389 
after ethanol feeding(51). 390 
 391 
Alcohol consumption is different from alcohol metabolism, but female mice seem to 392 
have an equal or increased consumption compared to males. Female mice will ingest 393 
more alcohol than their male counterparts if given free access to alcohol, although 394 
when access is restricted to a defined time period, their intake is similar(52). The 395 
females will also achieve higher blood alcohol levels after ingesting an equal amount 396 
of alcohol as male mice(52). This would also seem to mirror the human setting in 397 
which women need a lower alcohol intake to achieve equal blood levels to men 398 
(National Institute on Alcohol Abuse and Alcoholism. Women and alcohol 2015. 399 
Available from: http://pubs.niaaa.nih.gov/publications/womensfact/womensfact.htm. 400 
Accessed 14/09/15). Also, women that drank a moderate amount of alcohol were at 401 
higher risk of developing alcoholic liver disease than men that drank a similar 402 
amount(53, 54). All of the above underlines the importance of gender in induction of 403 
an alcoholic liver injury and reinforces the need to use mice of a single gender in 404 
murine models to achieve consistent results.  405 
 406 Comment [RW3]: Text added to expand and clarify the importance of gender as a variable affecting liver injury. 
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Age is also an important variable when investigating the effects of alcohol ingestion. 407 
Vogt et al. showed that glutathione levels take longer to recover after administration 408 
of alcohol in mice aged 24 months compared to mice at 12 months(55). This would 409 
appear to be replicated by other studies(56, 57). Glutathione is involved in the 410 
detoxification of alcohol and this result would seem to indicate that older mice are 411 
less able to metabolise repeated alcohol doses. Further work is required to establish 412 
whether this results in increased toxicity and an increased liver injury. However, 413 
Ramires et al. found an increased liver injury in mice over 24 months when compared 414 
with younger mice though this may be due to decreased rates of autophagy in the 415 
older mice(58). It is not clear whether age reduces a human’s ability to metabolise 416 
alcohol. Wynne et al. showed that age did not diminish the activity of alcohol 417 
dehydrogenase in the livers of male or female healthy volunteers(59). However, 418 
studies suggest that both age and ethnicity influence the severity of alcoholic liver 419 
disease in humans(60), and decline in mitochondrial function combined with 420 
accumulated oxidative damage in older individuals may render older livers more 421 
susceptible to damage from alcohol(61). Thus age is a variable that should be 422 
investigated more fully in the context of alcoholic hepatitis. 423 
 424 
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Comparison of mouse models to human AAH 425 
 426 
Inflammation of the liver caused by excess alcohol intake occurs after sustained 427 
excessive intake and consists of a combination of signs, symptoms and histological 428 
findings(62). Clinically, it causes a rapid onset of jaundice with fever, ascites and 429 
proximal muscle loss that may be accompanied by an enlarged and tender liver. 430 
Unfortunately, none of these parameters can be used to demonstrate the relevance 431 
of a mouse model to human disease. In patients, serum ALT/AST, bilirubin and INR 432 
are commonly raised and liver histology will reveal the presence of hepatocyte 433 
ballooning which represent amorphous eosinophilic inclusion bodies, called Mallory-434 
Denk bodies(63), and a high number of infiltrating neutrophils. Bilirubinostasis is 435 
common and associated with susceptibility to infection (64) and poor survival (65). 436 
Due to the long history of alcohol excess, steatosis and fibrosis are also commonly 437 
seen in human livers. 438 
  439 
The level of neutrophil infiltration in the murine liver has been suggested as a 440 
measure of how representative a model is of the picture of AAH seen in patients. 441 
However, a mouse model that induces a neutrophil infiltration similar to that seen in 442 
AAH has been elusive(66). Moreover, greater neutrophil infiltration is associated with 443 
better survival in humans (65) and thus may not be a sensible therapeutic target. 444 
Two older models that have been used in this context are the 3,5-diethoxycarbonyl-445 
1,4-dihydrocollidine (DDC) or griseofulvin (GF) models. These produce ballooning of 446 
hepatocytes and accumulation of Mallory bodies but do not involve the administration 447 
of alcohol to the mice.  448 
 449 
Lamle et al. were able to induce inflammation within the livers of the Nrf2-/- mice that 450 
received Lieber deCarli and ethanol diet which was characterised by histological 451 
finding of Kupffer cell and neutrophil infiltration of the liver(7). The chronic-binge 452 
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alcohol feeding method also seems to induce a liver injury that is reasonably similar 453 
to human AAH and Bertola et al. describe raised serum ALT/AST, TNF and hepatic 454 
neutrophil infiltration in this model albeit without describing the other characteristic 455 
histological findings such as hepatocyte ballooning found in human AAH(17). 456 
 457 
Human alcoholic hepatitis(AH) commonly occurs after repeated, long-term alcohol 458 
ingestion with an acute flare up producing the inflammation. It may be that our mouse 459 
models do not reflect this longer term ingestion and thus do not produce the same 460 
phenotype of disease. This is supported by the findings of cirrhosis in human 461 
biopsies which is not normally reflected in the mouse models. An elevated bilirubin is 462 
not reproduced by any of the mouse models which may indicate that this feature is 463 
linked to the more chronic features of the disease, although how this occurs still 464 
needs further clarification. 465 
 466 
In the search for murine model/human disease crossover, Xu et al. identified murine 467 
hepatic Fsp27 and the human homolog Cidec(67). Both genes are elevated in 468 
correlation within a setting of AAH and Fsp27 is thought to be upregulated by 469 
ChREBP and Ppar-γ. Interestingly, Cidec up-regulation was found to correlate with 470 
the degree of hepatic steatosis, severity of disease and the mortality of the AH 471 
patients. Xu et al. were able to show that knocking out Fsp27 in the mouse, 472 
ameliorated the liver injury seen. This suggests that Cidec may be a therapeutic 473 
target that could reduce the level of liver injury sustained by patients with AH. 474 
 475 
Standardisation of endpoints for use in models of alcohol-induced liver injury 476 
 477 
The literature includes a range of different read-outs and experimental endpoints that 478 
are used to quantify the nature and severity of alcohol-induced liver injury. This 479 
diversity can be useful for understanding pathogenesis but is challenging when trying 480 
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to compare the phenotype of liver damage reported across different models. 481 
Moreover, there is value in tailoring the read-outs to the focus of a particular study or 482 
clinical discipline, whether it is generation of steatosis, inflammation, fibrosis or 483 
cancer. Certain analyses are useful in the majority of studies, such as serum ALT 484 
levels, whereas other tests will be specific for the question being asked, such as the 485 
amount of fibrosis as indicated by alpha-smooth muscle actin. Detail of some of the 486 
more common experimental parameters is given below and summarised in Table 3. 487 
 488 
Overall assessment of murine behaviour and well-being 489 
Murine behavioural patterns are often monitored with a view to animal welfare, 490 
although their assessment with standardised scoring systems can provide important 491 
information on the effect of alcohol on the mouse. Done reliably, such scoring 492 
systems have the potential to provide objective information on the severity of illness 493 
in mice thus providing a censorable end-point for experiments, whether they be 494 
induction of injury or response to treatment (Supplemental Table S1). This bears 495 
comparison with clinical scoring systems such as the Glasgow alcoholic hepatitis 496 
score (GAHS), which increasingly focus on clinical features of function rather than 497 
static measures of liver damage. Given the reported individual variation in level of 498 
liver damage following some murine models of ethanol exposure, the added 499 
advantage of a clinical assessment is that it ensures mice are more likely to have 500 
developed a similar level of liver damage. 501 
 502 
Biochemical assessment of liver function 503 
In the setting of severe liver injury, the most robust assessment of a model should 504 
include measurement of parameters of liver synthetic function such as prothrombin 505 
time, serum bilirubin, glucose and albumin levels. These provide important 506 
information on the severity of injury, and can be performed on peripheral blood 507 
samples whilst models are ongoing thus allowing for the rigorous assessment of 508 
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potential new therapies. However, as mice have approximately 50-60 ml/kg of 509 
circulating blood (approximately 1.5 ml for a 25 gram mouse) (National centre for the 510 
replacement raroair. Mouse : Decision tree for blood sampling. Available from: 511 
http://www.nc3rs.org.uk/mouse-decision-tree-blood-sampling. Accessed 14/09/15), 512 
there are limitations on the number of blood tests that can ethically and 513 
physiologically be performed on living animals.  514 
 515 
Assessment of liver damage and hepatocyte death 516 
Liver damage, as opposed to function, can be assessed in a variety of ways ranging 517 
from measurement of serum ALT/AST through to scoring of liver histology. Serum 518 
ALT/AST are commonly measured in studies and provide a standardised 519 
measurement of liver damage. This is generally used to compare the extent of liver 520 
damage across studies using different models and different strains of mice, although 521 
there is strain-dependent difference in susceptibility to injury. For example, Mizuhara 522 
et al. have shown that ALT levels vary significantly between C57Bl/6 and BALB/c 523 
mice following induction of liver injury with concanavalin A(68). Haematoxylin & Eosin 524 
(H&E) staining of liver sections provides valuable information on the extent of tissue 525 
necrosis, inflammation and steatosis, and TUNEL staining can allow quantification of 526 
the amount of apoptosis. Histological analysis for the presence of hepatocyte 527 
ballooning and presence of Mallory bodies by ubiquitin staining(69) is of particular 528 
relevance in the setting of AAH, whilst analyses of superoxide dismutase 1 (SOD1) 529 
and malondialdehyde (MDA) may provide useful insights into the level of oxidative 530 
stress during acute liver injury(70). 531 
 532 
Assessment of liver steatosis 533 
Although H&E staining gives a qualitative indication as to the extent of steatosis, 534 
quantitative assessment can be performed using Oil Red O staining of liver sections 535 
and digital imaging or morphometric analysis alongside quantification of hepatic 536 
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triglycerides and lipids. Liver to body weight ratio can also provide an indication of 537 
the extent of steatosis although it can be confounded by concomitant liver necrosis. 538 
More detailed analysis of steatosis can also include analysis of key molecules in 539 
pathways contributing to its development, such as SREBP, which are involved in 540 
cholesterol and fatty acid biosynthesis(71). 541 
 542 
Assessment of liver inflammation 543 
Immunohistochemical staining of liver provides data on the extent and composition of 544 
liver infiltrating inflammatory cells, which can be complemented by flow cytometric 545 
analysis of resident immune cells from liver cell digests. For example neutrophil 546 
infiltration in models of alcoholic hepatitis has been assessed using both 547 
immunochemical staining(72) and cytometric detection of Ly6G positive cells in liver 548 
digests(73). Cell digest analysis can provide detailed quantitative information on the 549 
composition of the liver infiltrate as well as determination of the activation status of 550 
any infiltrating cells. This can also be supplemented with analysis of cytokines, such 551 
as tumour necrosis factor (TNF), IL-6 and IL-10, from serum and liver tissue at 552 
message and protein level to provide useful information on the level of inflammation 553 
and the impact of any therapeutic intervention(74). For example, in humans, IL-6, IL-554 
8, TNF and MCP-1 have all been implicated in neutrophil infiltration in patients with 555 
alcoholic hepatitis(75) (76), whilst in mice IL-4 appears to promote neutrophil survival 556 
and hepatitis(77).  557 
 558 
Assessment of liver fibrosis 559 
Standardised assessment of liver fibrosis should include morphometric analysis of 560 
fibrotic areas by picrosirius red (PSR) or Van Gieson staining, qPCR for Col1 561 
transcripts and biochemical assays of fibrosis such as hepatic hydroxyproline 562 
quantification(78). Useful additional insights can be gained by studying staining for 563 
activated hepatic stellate cells using alpha-smooth muscle actin (α-SMA) and 564 
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transcription levels of matrix metallo-proteinases (MMP) and their tissue inhibitors 565 
(TIMP). 566 
 567 
Additional mechanistic studies 568 
Existing mouse models are useful in replicating human disease but, as discussed 569 
above, they have limitations. One interesting area that could be expanded upon in 570 
the future is the use of genome wide association studies (GWAS) to identify human 571 
pathways/molecules involved in alcoholic liver injury. Current results from these 572 
studies have helped identify an allele that has an association with alcoholic liver 573 
injury(79). Other studies have identified specific genes that have a role in the 574 
pathogenesis of alcoholic liver injury, such as osteopontin(80). There is potential to 575 
expand on this work to identify further genes that put individuals at risk of developing 576 
severe alcoholic liver injury. This clinical information could be used to create new 577 
transgenic mice to investigate pathways involved in alcohol metabolism, help future 578 
refining of animal models and discover new treatments for alcoholic liver disease. 579 
 580 
Thus, future mechanistic studies may consider useful biomarkers to identify 581 
individuals at risk of experiencing alcoholic liver injury(81). Manna et al. used 582 
metabolomics to show that indole-3-lactic acid and phenyl lactic acid are potential 583 
biomarker candidates(82), while microarray data has identified that serum insulin-like 584 
growth factor binding protein 1 could provide an easily measured biomarker for early 585 
detection of alcohol-induced liver injury(83). The Szabo group reported that 586 
microRNAs may serve as biomarkers that can differentiate between hepatocyte 587 
inflammation and injury. They found that different miRNAs can be elevated by either 588 
alcoholic, drug-induced or inflammatory liver disease(84). 589 
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Conclusion 590 
 591 
In conclusion, murine models of alcoholic liver disease are an invaluable tool that can 592 
be used to investigate the whole spectrum of alcohol-induced liver damage 593 
encountered in the human population. Murine models have several advantages 594 
which allow researchers to investigate the full time-course and specific mechanisms 595 
of the disease in more depth than is possible from human studies. It is clear that 596 
before commencing any mouse model work, the human liver injury feature to be 597 
replicated must be identified. When this is known, a specific mouse model can be 598 
chosen by selecting a transgenic mouse, the alcohol administration method and the 599 
duration/amount of alcohol required to replicate that clinical picture. However, 600 
researchers should exert caution and ensure that factors such as gender, age and 601 
strain of mice are carefully considered. This is vital to ensure the mouse liver injury 602 
mirrors that seen in patients and thus provides a robust means in which to test new 603 
pathophysiological mechanisms or therapeutic agents.  604 
 605 
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Tables 606  607 
Mode of Delivery Liver histology findings Change in serum ALT Practical/resource issues 
Ad Libitum- Water + Ethanol 
(11),(85) (86), (87) 
Histologically normal liver or mild steatosis 
only. 
Minimal or no rise in ALT up to 
160 U/L. 
Easy to deliver. 
Ad libitum- Lieber-DeCarli diet 
+ Ethanol  (8), (10), (17), (28), 
(88), (89), (90), (91), (92) 
Histological evidence of mild to moderate 
micro and macrosteatosis only. 
Variable rise in ALT from a 
minimal increase up to 350 U/L 
with long term feeding. 
Easy to deliver, special diet 
needed. 
Acute gavage (16), (93) 
Histological evidence of mild steatosis and 
inflammatory injury only. 
A rise of between 30 to 50 U/L. Skill needed for gavage technique. 
Ad libitum + gavage (18), (19), 
(22) 
Histological evidence of neutrophil infiltration 
into the liver. Steatosis with occasional areas 
of necrosis, but no fibrosis. 
Increase of up to 270 U/L. Skill needed for gavage technique. 
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 608  609 
Table 1- Established routes for administration of alcohol to mice 610 
 611 
Intra-gastric infusion (21), (71), 
(94), (95), (96), (97) 
Histological evidence of severe steatosis, 
inflammation, necrosis and hepatic stellate 
activation. 
ALT up to 450 U/L. 
Specialist surgical skill needed, 
extensive amount of specialist 
equipment and intensive monitoring 
needed. 
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Genetic manipulation Function of key gene Liver injury indices Conclusions 
Hepatic ADH knockout, ad 
libitum LdC + 1, 2 or 3.5% 
EtOH (98), (99) 
ADH catalyses the oxidation of 
ethanol - the main pathway by 
which ethanol is metabolized 
during chronic alcohol abuse. 
No significant oxidative stress levels 
or inflammatory response. Produced 
pan lobar vacuolization in response to 
3.5% EtOH diet. 
Dose of ethanol and ADH 
deficiency are key factors in 
initiation and progression of 
alcoholic fatty liver disease. The 
ADH KO mice produced higher 
BALs(99) and consequently 
increased hepatic lipid 
vacuolization.  Deer mice and 
this model can be used to study 
chronic alcoholic liver injury. 
BiP (heavy chain 
immunoglobulin binding 
protein/ Grp78) knockout, ad 
libitum high fat diet + 4 g 
BiP mediates the unfolded protein 
response which reduces protein 
translation, enhances protein 
folding and increases degradation 
Raised ALT to approximately 320 U/L 
in BiP KO mice compared to 
approximately 45 U/L in WT mice. 
Also showed increased lipid 
HCCs were only found in the 
knockout mice, suggesting that 
more than one ‘insult’ needs to 
be present to induce 
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alcohol/kg body weight(89) of unfolded proteins. This serves 
as a model of ER stress with 
alcohol added to study the 
development of hepatocellular 
carcinoma (HCC). 
accumulation and increased rate of 
HCC. 
carcinogenesis. Alcohol induced 
stress was age related, with 
younger animals more resistant 
to stress. 
CHOP knockout, intra gastric 
infusion of high fat diet + 18 
g/kg/day increased to 29 
g/kg/day of alcohol for a total 
of 4 weeks(100) 
CHOP is a transcriptional regulator 
involved in apoptosis caused by 
endoplasmic reticulum stress. 
WT & transgenic mice had significant 
changes in steatosis score, liver 
triglyceride levels (fivefold increase in 
WT but 50% decrease in CHOP -/- 
mice) and ALT (112 U/L). CHOP -/- 
mice had no apoptosis. 
As a response to ER stress, 
CHOP upregulates and is 
involved in causing apoptosis. 
Cyp2e1 knockout, intra 
gastric infusion of high fat 
diet + 14 g/kg/day increased 
to 28g/kg/day of alcohol for a 
Cyp2e1 (cytochrome P450) is 
induced in the hepatocyte by 
ethanol and appears to correlate 
with the level of liver injury. 
Mild steatosis, slight inflammation and 
necrosis as shown by pathology 
scores. 
Shows that CYP2E1 has a 
minimal role in early alcohol 
induced liver injury. 
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total of 4 weeks(97) 
Gsta4-4/Ppara double 
knockout, ad libitum 5% 
EtOH/ LdC for 40 days(35) 
Gsta4-4 (Glutathione S-transferase 
A4-4) is a detoxification enzyme 
that eliminates toxins via 
glutathione conjugation. Ppar-α is a 
hormone receptor that regulates 
hepatic inflammation and lipid 
metabolism. 
Produces increased hepatic injury 
with significantly increased 
inflammatory response, necrosis and 
fibrosis. 
Shows the importance of lipid 
peroxidation products mediating 
the early progression of ALD. 
Hfe knockout, High fat diet 
and  ad libitum water + 
alcohol at 20% v/v for 8 
weeks(9) 
Model of iron overload consistent 
with haemochromatosis. 
Produces profound steatohepatitis, 
significant fibrosis and increased 
apoptosis. 
Highlights a combined effect of 
iron overload, alcohol and a high 
fat diet cause significant 
steatosis, inflammation, 
oxidative stress and apoptosis. 
Hif-1a knockout mice, ad 
libitum 6% ethanol/LdC diet 
HIF (hypoxia inducible factor) is a 
master controller adapting to 
Increased steatosis, serum and liver 
cholesterol and triglycerides. 
HIF-1a induction provides 
protection against alcohol 
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for 4 weeks(29) hypoxia by controlling expression 
of hundreds of genes. 
induced fatty liver disease and 
modulating its activity may 
provide therapeutic potential.   
Lipin-1 knockout, ad libitum 
low fat LdC + alcohol for 4 
weeks*(28) 
Lipin-1 is a vital regulator of lipid 
metabolism. 
Produces an ALT of 90 U/L with 
fibrosis in Lipin-1 knockout mice after 
4 weeks of feeding. 
Suggests a role for treatments to 
enhance lipin-1 as a treatment 
for ALD. 
Nrf2 knockout, ad libitum 
LdC + 2.1% v/v alcohol for 
3/7, 4.2% for 3/7 followed by 
6.3% alcohol until the mice 
became moribund(7) 
Nuclear factor-erythroid 2-related 
factor 2 (NrF2) is a transcription 
factor that protects against 
oxidative stress. 
An ALT of 3000 U/L and severe 
steatosis with increased number of 
Kupffer cells. 
Central role for Nrf2 in the 
protection against alcohol 
induced liver injury. 
Ppara knockout, gavage of 
0.4ml/10g 52% erguotou 
wine for 4/52(8) 
Pparα stimulates fatty acid 
catabolism under fasting conditions 
(similar to chronic alcohol 
ingestion). 
Fibrosis in knockout mice fed ethanol 
for 4-6 months, with severe steatosis 
and inflammatory cell infiltration. 
Suggests a pathway for alcohol 
metabolism. Possible role for 
Pparα agonists in treatment of 
ALD. 
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Srebp-1c knockout, intra-
gastric infusion of high fat 
diet + 18 g/kg/day of alcohol 
increased to 29 g/kg/day for 
a total of 4 weeks(71) 
Sterol response binding proteins 
(SREBP) are normally induced in 
the liver by alcohol. They have an 
essential role in hepatic triglyceride 
and cholesterol synthesis. 
ALT rise up to 118 in WT mice and 80 
in Srebp-1c-/- mice with a steatosis 
score of 3.2 in WT and 0.9 in 
knockout mice. 
Shows that hepatic triglyceride 
accumulation is dependent on 
Srebp-1c. 
Stat3 knockout, ad libitum 
LdC + 5% alcohol for 10/7 
followed by a gavage of 5 
g/kg of alcohol(18) 
Involved in the activation of IL-22- 
a cytokine involved in controlling 
bacterial infection, homeostasis 
and tissue repair. 
Produces significantly higher ALT 
(300 U/L), AST (450 U/L) + 
triglycerides (50 mg/g), with  
microsteatosis. 
Shows the hepatoprotective role 
of IL-22 is dependent on Stat3. 
TNFR1 knockout, intra-
gastric infusion of high fat 
diet + 18 g/kg/day of alcohol 
increased to 29 g/kg/day for 
a total of 4 weeks(95) 
Tumour Necrosis Factor α(TNFα) is 
released by Kuppfer cells primed 
by gut endotoxins and plays a 
major role in early alcoholic liver 
injury- It’s effect is stopped if its 
receptor (TNFR1) is knocked out. 
Knock-out mice have smaller 
increases in ALT (45 vs 115 U/L), liver 
triglycerides (0.27 vs 0.34 mg/mg), 
inflammatory foci and apoptotic cells 
than WT mice. 
ALD has multiple complex 
pathways, TNFα has a modest 
contribution to the liver injury 
seen. 
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 612 
Table 2. Summary of current transgenic models of alcohol induced liver injury. Abbreviations: ADH- Anti diuretic hormone, ALT- Alanine 613 
transaminase, AST- Aspartate transaminase, CHOP- C/EBP-homologous protein of 29 kDa, EtOH- Ethanol, Stat3- signal transducer and 614 
activator of transcription 3. 615 
* Ethanol level calculated according to percentage of calories in the liquid diet. Mice given 29% of the daily calories as ethanol.616 
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Phenotype of 
liver injury 
Blood analyses Histological assessment Flow cytometry PCR 
Steatosis 
Serum AST/ALT, Triglycerides, 
free fatty acids, cholesterol. 
H&E staining, Oil Red O 
staining. 
Fatty Acid Synthase. Chrebp/ Srebp, TNF-α. 
Acute alcoholic 
hepatitis 
Serum AST/ALT, markers of 
synthetic function (PT or bilirubin) 
and TNF, IL-6, IL-10. 
CD45, CD68, CD11b, 
MPO staining. 
Identification of inflammatory 
cells i.e. CD3, CD4, CD8, 
CD19 & CD45. 
Sod1, Stat3, GRP-78, 
GRP-94. 
Fibrosis  
Van Gieson or Picro sirius 
red staining. 
α-SMA. Col1, MMP, TIMP. 
 
Table 3. Summary of suggested tests according to phenotype of liver damage being established.  
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